Breast Cancer News and Research

Latest Breast Cancer News and Research

Australian-New Zealand hormone therapy trial good news for prostate cancer patients

Results of a major trial of hormone therapy on men with locally advanced prostate cancer announced today were a significant development and would be welcomed by patients and oncologists world-wide, according to The Cancer Council Australia.

23 May 2005

High-dose Tamoxifen may prolong survival in amyotrophic lateral sclerosis (ALS)

Neurologist Benjamin Brooks, who directs the MDA ALS Center at the University of Wisconsin-Madison, presented results of a trial of tamoxifen, a drug approved for the treatment of breast cancer, at a meeting of the American Academy of Neurology in April. The trial was supported in part by MDA.

23 May 2005

Market forces alone are not sufficient to produce new drugs needed for children with cancer

Faced with "a near absence of research in pediatric cancer drug discovery," the IOM report recommends forming new public-private partnerships among government, industry, researchers, advocacy groups and other parties to lead research and development.

23 May 2005

New polysaccharide may help combat multidrug resistance in cancer

In a recent study published in the Journal of Biological Chemistry, scientists report that a molecule previously thought to play a purely structural and inert role in cells is actually involved in multidrug resistance in cancer.

22 May 2005

CAD system makes breast MRI more effective, efficient

A computer-aided detection (CAD) system is helping radiologists to more quickly and accurately determine the sizes and locations of cancers found on breast MRI—information that could change patients’ treatment, a new study shows.

20 May 2005

Studies on Hormone Replacement Therapy (HRT) for breast cancer patients can give false hopes

Women treated for breast cancer who are considering taking Hormone Replacement Therapy (HRT) should be cautious when using published research to inform their decision. An article published today in the journal Breast Cancer Research reveals that qualitative studies on the recurrence of breast cancer in breast cancer survivors undergoing HRT are unreliable.

20 May 2005

Birth weight and breastfeeding in infancy may affect premenopausal breast cancer risk

Premenopausal women who were heavier than average at birth or had not been breastfed as infants appear to be at increased risk for developing breast cancer, epidemiologists at the University at Buffalo's School of Public health and Health Professions have found.

19 May 2005

Advanced breast cancer drug appears effective on multiple targets

An experimental breast cancer drug that simultaneously attacks five tumor targets has halted progression of the disease in a clinical trial for patients with advanced disease.

18 May 2005

Breast cancer chemotherapy regimen associated with life-threatening complications

The chemotherapy regimen of doxorubicin plus docetaxel, used to treat breast cancer in a clinical trial, was associated with an increased risk of serious complications, resulting in the premature termination of the trial, according to a study in the May 18 issue of JAMA.

17 May 2005

Doxorubicin-docetaxel combination is associated with an increased risk of severe and life-threatening complications

Researchers in France say a study using two chemotherapy agents to treat breast cancer was halted after two women in the study died.

17 May 2005

Postmenopausal women who follow a low-fat diet have 24 percent less chance of a recurrence of breast cancer

The study by Rowan T. Chlebowski and colleagues at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, involved 2,437 women aged 48 to 79 who were diagnosed with early stage breast cancer and were treated at several medical centers. All the women had the standard treatments such as surgery, radiation therapy, and chemotherapy and or tamoxifen therapy.

17 May 2005

Unlucky news for Kylie Minogue

The 36-year-old Australian Pop Diva was diagnosed with breast cancer while visiting her family at home in Melbourne, her management confirmed.

17 May 2005

New drug combination prevents breast cancer growth pre-surgery

A new type of drug originally developed for lung cancer can reduce the size of breast cancer tumours when taken in combination with other drugs.

17 May 2005

Gefitinib (Iressa) could reduce the size of breast cancer tumours

Giving women with early breast cancer a drug called gefitinib (Iressa) before surgery could reduce the size of their tumours, suggests a randomised trial published online today by The Lancet Oncology.

17 May 2005

Patients with suspicious axillary lymph nodes in their breasts should first undergo ultrasound-guided fine-needle aspiration to avoid unnecessary surgery

Currently, breast cancer patients undergo axillary lymph node dissection for accurate staging and control of the cancer. In many cases, this major procedure can be replaced by sentinel lymph node biopsy, which is a more simple and less invasive surgical procedure, but many still have to undergo axillary dissection after the sentinel lymph node biopsy.

17 May 2005

Antibody combined with cancer drug shows promise against breast tumors

An antibody that targets the blood vessels nourishing tumors significantly reduced breast cancer formation and growth in mice when combined with a current cancer drug, according to researchers at UT Southwestern Medical Center.

16 May 2005

Combined MRI and mammography more effective at detecting breast cancer in high risk women

Annual screening, using magnetic resonance imaging (MRI) and X-ray mammography, is the best way to detect breast cancer in women that have a high genetic risk of the disease, according to a study published online by The Lancet.

16 May 2005

Statins appear to lessen chance of developing breast cancer

According to a new study women who are taking the cholesterol-lowering drugs called statins, such as Lipitor or Mevacor, appear to have much less chance of developing breast cancer.

16 May 2005

Bevacizumab (Avastin) combined with low-dose chemotherapy slows ovarian cancer

A targeted cancer drug given with low-dose chemotherapy shrank ovarian tumors and slowed progression of ovarian cancer in patients with recurrent disease, according to research findings presented by Agustin Garcia, M.D., principal investigator of the study and Director of Breast Cancer Research at the Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center.

16 May 2005

Tarvacin equivalent plus Docetaxel inhibits breast tumor growth by 93%

Peregrine Pharmaceuticals, Inc., today announced that a research article titled "A Monoclonal Antibody that Binds Anionic Phospholipids on Tumor Blood Vessels Enhances the Antitumor Effect of Docetaxel on Human Breast Tumors in Mice" was published in the May 15 issue of Cancer Research.

16 May 2005

Breast Cancer News and Research

Latest Breast Cancer News and Research

Australian-New Zealand hormone therapy trial good news for prostate cancer patients

High-dose Tamoxifen may prolong survival in amyotrophic lateral sclerosis (ALS)

Market forces alone are not sufficient to produce new drugs needed for children with cancer

New polysaccharide may help combat multidrug resistance in cancer

CAD system makes breast MRI more effective, efficient

Studies on Hormone Replacement Therapy (HRT) for breast cancer patients can give false hopes

Birth weight and breastfeeding in infancy may affect premenopausal breast cancer risk

Advanced breast cancer drug appears effective on multiple targets

Breast cancer chemotherapy regimen associated with life-threatening complications

Doxorubicin-docetaxel combination is associated with an increased risk of severe and life-threatening complications

Postmenopausal women who follow a low-fat diet have 24 percent less chance of a recurrence of breast cancer

Unlucky news for Kylie Minogue

New drug combination prevents breast cancer growth pre-surgery

Gefitinib (Iressa) could reduce the size of breast cancer tumours

Patients with suspicious axillary lymph nodes in their breasts should first undergo ultrasound-guided fine-needle aspiration to avoid unnecessary surgery

Antibody combined with cancer drug shows promise against breast tumors

Combined MRI and mammography more effective at detecting breast cancer in high risk women

Statins appear to lessen chance of developing breast cancer

Bevacizumab (Avastin) combined with low-dose chemotherapy slows ovarian cancer

Tarvacin equivalent plus Docetaxel inhibits breast tumor growth by 93%

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in